Clinical Trial Update: Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared lercanidipine hydrochloride (Zanidip) with felodipine sustained-release for hypertension; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Felodipine sustained-release tablet (felodipine)
• Zanidip (lercanidipine hydrochloride)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Hypertension | Phase 4 | Status: COMPLETED